_1777370193195_831968492.png&w=64&q=75){kind=small}
Trump Highlights Joe Rogan's ibogaine
President Trump has renewed efforts to advance research into ibogaine, a psychoactive compound used for treating substance use disorders, especially opioid cravings. An executive order signed in April directed federal agencies to accelerate studies and funding, leading to initial FDA trials. Recently, Trump announced that the University of Miami has provided the original 1994 FDA application for ibogaine, potentially facilitating its development as a medical treatment in the U.S.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)